dacarbazine has been researched along with Blood Diseases in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (9.09) | 18.7374 |
| 1990's | 6 (13.64) | 18.2507 |
| 2000's | 14 (31.82) | 29.6817 |
| 2010's | 20 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, T; Jalali, R; Mohanty, S; Moiyadi, A | 1 |
| De Sanctis, V; Enrici, RM; Minniti, G; Scaringi, C | 1 |
| Carter, AF; DeTroye, AT; Harmon, MS; Lesser, GJ; Morrell, RM; Tooze, JA | 1 |
| Amadori, A; Berti, F; Bertorelle, R; Della Puppa, A; Farina, P; Lombardi, G; Marcato, R; Rumiato, E; Sacchetto, V; Saggioro, D; Zagonel, V; Zustovich, F | 1 |
| Arakawa, Y; Fujimoto, K; Kikuchi, T; Kunieda, T; Miyamoto, S; Mizowaki, T; Murata, D; Takagi, Y; Takahashi, JC | 1 |
| Mukasa, A; Narita, Y; Saito, K; Saito, N; Shibui, S; Shinoura, N; Tabei, Y | 1 |
| Claringbold, PG; Kesavan, M; Turner, JH | 1 |
| Kolarović, J; Lalić-Popović, M; Lalošević, D; Mikov, M; Milijašević, B; Stefanović, D; Tomić, Z | 1 |
| Bae, SH; Cho, SY; Kim, CY; Kim, TM; Kim, YH; Kim, YJ; Lee, MM; Lee, SH; Park, CK; Park, MJ | 1 |
| Balañá, C; Belda-Iniesta, C; Berrocal, A; Capellades, J; Gallego, O; Gil-Gil, M; La Orden, B; Ordoñez, JM; Pérez-Segura, P; Reynés, G; Sepúlveda, JM | 1 |
| Han, JH; Joo, JD; Kim, CY; Kim, H; Kim, YH | 1 |
| Dario, A; Tomei, G | 1 |
| Aikin, AA; Balis, FM; Cole, DE; Fox, E; Meany, HJ; Warren, KE | 1 |
| Bozhenko, VK; Datsenko, PV; Pan'shin, GA; Podol'skiĭ, PN; Sotnikov, VM | 1 |
| Achawal, S; Dixit, S; Hingorani, M; Scott, I | 1 |
| Auberdiac, P; Cartier, L; Chargari, C; Forest, F; Fotso, MJ; Magné, N; Malkoun, N; Nuti, C; Pacaut, C; Peoc'h, M; Schmitt, T; Thorin, J | 1 |
| Buesa, JM; Carrasco, JA; Casado, A; Cruz, J; Cubedo, R; de Andrés, R; De Juan, A; Fra, J; García-Del-Muro, X; Gómez-España, A; Laínez, N; López-Pousa, A; Martín, J; Martínez-Trufero, J; Maurel, J; Meana, A; Pericay, C; Poveda, A; Rubió, J | 1 |
| Abdur, S; Bressler, LR; Letarte, N; Villano, JL; Yu, JM | 1 |
| Arpa, D; Cardali, S; Conti, A; De Renzis, C; Granata, F; Pontoriero, A; Romanelli, P; Siragusa, C; Tomasello, C; Tomasello, F | 1 |
| Boro, J; Cheung, MC; Ezzat, HM; Harris, M; Hicks, LK; Leitch, HA; Lima, VD; Montaner, JS | 1 |
| Becker, M; Gao, D; Gonzalez, R; Kounalakis, N; Lewis, K; McCarter, M; Pearlman, N; Poust, J; Robinson, W | 1 |
| Advani, R; Bartlett, NL; Cheson, BD; Connors, JM; Evens, AM; Fisher, RI; Gascoyne, RD; Gordon, LI; Gospodarowicz, M; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Miller, TP; Stiff, PJ; Wagner, H | 1 |
| Bedikian, AY; Eton, O; Papadopoulos, N; Plager, C; Ring, S | 1 |
| Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M | 1 |
| Bamberg, M; Dichgans, J; Küker, WM; Steinbach, JP; Weller, M; Wick, W | 1 |
| Carpentier, A; Cartalat-Carel, S; Chinot, O; Cougnard, J; Delattre, JY; Djafari, L; Duffau, H; Gervais, H; Hoang-Xuan, K; Honnorat, J; Laigle, F; Mokhtari, K; Napolitano, M; Sanson, M; Taillandier, L; Taillibert, S | 1 |
| Eggermont, AM; Kirkwood, JM | 1 |
| Wong, ET | 1 |
| Buesa, JM; Del Muro, JG; Escudero, P; Esteban, E; Fra, J; Gión, M; Goitia, A; López-Pousa, A; Losa, R; Maurel, J; Nadal, R; Sierra, M; Uña, E | 1 |
| Dunder, K; Ekeblad, S; Eriksson, B; Granberg, D; Janson, ET; Kindmark, H; Kozlovacki, G; Oberg, K; Orlefors, H; Sigurd, M; Skogseid, B; Sundin, A; Welin, S | 1 |
| Ashley, DM; Coleman, LT; Downie, PA; Heath, JA; Khaw, SL | 1 |
| Engstrom, PF; Klaassen, DJ; MacIntyre, JM; Mittelman, A | 1 |
| Aviles, A; Delgado, S | 1 |
| Aamdal, S; Andersson, R; Bjelkengren, G; Ingvar, C; Jungnelius, U; Karlsson, M; Malmström, P; Mattsson, J; Ringborg, U; Stierner, U; Westberg, R; Willman, K; Wist, E | 1 |
| Heere-Ress, E; Hoeller, C; Hoermann, M; Hollenstein, U; Jansen, B; Lucas, T; Pehamberger, H; Schlagbauer-Wadl, H; Wacheck, V; Wolff, K | 1 |
| Achtelik, W; Dummer, R; Ellwanger, U; Fey, M; Garbe, C; Hauschild, A; Kaufmann, R; Linse, R; Mohr, P; Nashan, D; Sebastian, G; Seiter, S; Stolz, W; Tilgen, W; Ugurel, S; Ulrich, J | 1 |
| Carde, P; Cavalli, F; Diehl, V; Franklin, J | 1 |
| Buesa, JM; Mouridsen, HT; Poveda, A; Steward, W; Sylvester, R; Thomas, D; van Oosterom, AT; Verweij, J; Vestlev, PM; Wagener, T | 1 |
| Bajorin, DF; Chapman, PB; Cody-Johnson, BV; Heelan, RT; Lovett, DR; Oettgen, HF; Portlock, CS; Steffens, TA; Templeton, MA; Wong, GY | 1 |
| Buzaid, AC; Durivage, HJ; Murren, JR | 1 |
| Davis, C; DeRosa, W; Durivage, HJ; Makuch, R; Murren, JR; Portlock, CS | 1 |
| Bey, P; Conroy, T; Lederlin, P; Peiffert, D; Witz, F | 1 |
| Bellet, RE; Berd, D; Mastrangelo, MJ; McClay, EF; Sprandio, JD | 1 |
| Baker, LH; Cummings, G; Haas, CD; Samson, MK | 1 |
6 review(s) available for dacarbazine and Blood Diseases
| Article | Year |
|---|---|
Temozolomide-related hematologic toxicity.
Topics: Antineoplastic Agents, Alkylating; Comorbidity; Dacarbazine; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Hematologic Diseases; Humans; Incidence; Neoplasms; Risk Factors; Temozolomide; Treatment Outcome | 2013 |
The safety of the temozolomide in patients with malignant glioma.
Topics: Adult; Antineoplastic Agents, Alkylating; Child; Clinical Trials as Topic; Dacarbazine; Drug Interactions; Glioma; Hematologic Diseases; Humans; Infections; Nausea; Temozolomide; Vomiting | 2006 |
The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Dacarbazine; Decanoic Acids; Drug Implants; Glioblastoma; Hematologic Diseases; Humans; Middle Aged; Multicenter Studies as Topic; Polyesters; Postoperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Temozolomide; Venous Thromboembolism; Young Adult | 2011 |
Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Hematologic Diseases; Humans; Melanoma | 2004 |
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hodgkin Disease; Humans; Infertility; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Treatment Outcome; Vinblastine; Vincristine | 2000 |
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematologic Diseases; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine | 1989 |
20 trial(s) available for dacarbazine and Blood Diseases
| Article | Year |
|---|---|
Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment: A Prospective Study.
Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Hematologic Diseases; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Proton Pump Inhibitors; Temozolomide; Tumor Suppressor Proteins | 2015 |
Hematological toxicity of combined 177Lu-octreotate radiopeptide chemotherapy of gastroenteropancreatic neuroendocrine tumors in long-term follow-up.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Blood Platelets; Capecitabine; Dacarbazine; Deoxycytidine; Digestive System Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Hematologic Diseases; Humans; Incidence; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Neutrophils; Octreotide; Pancreatic Neoplasms; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Stomach Neoplasms; Temozolomide; Thrombocytopenia; Treatment Outcome | 2014 |
A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dacarbazine; Feasibility Studies; Female; Follow-Up Studies; Glioblastoma; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Temozolomide | 2015 |
Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dacarbazine; Dose-Response Relationship, Drug; Drug Interactions; Female; Guanine; Hematologic Diseases; Humans; Male; Neoplasms; Sex Factors; Tandem Mass Spectrometry; Temozolomide; Young Adult | 2009 |
Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dacarbazine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gastrointestinal Diseases; Gemcitabine; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Spain; Treatment Outcome; Young Adult | 2011 |
Efficacy and toxicity of CyberKnife re-irradiation and "dose dense" temozolomide for recurrent gliomas.
Topics: Antineoplastic Agents, Alkylating; Asthenia; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiosurgery; Reoperation; Survival Rate; Temozolomide; Vomiting | 2012 |
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2013 |
Phase II evaluation of temozolomide in metastatic choroidal melanoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Choroid Neoplasms; Dacarbazine; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Prospective Studies; Temozolomide; Treatment Outcome | 2003 |
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Female; Gastrointestinal Diseases; Glioblastoma; Hematologic Diseases; Humans; Male; Middle Aged; Prospective Studies; Remission Induction; Salvage Therapy; Supratentorial Neoplasms; Survival Analysis; Temozolomide; Treatment Outcome | 2004 |
Initial chemotherapy in gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Karnofsky Performance Status; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Neuroepithelial; Oligodendroglioma; Procarbazine; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine | 2004 |
Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas.
Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Aspartate Aminotransferases; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Hematologic Diseases; Humans; Ifosfamide; Infusions, Intravenous; Liver; Lung; Male; Middle Aged; Remission Induction; Sarcoma; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydroxyurea; Male; Middle Aged; Mitomycins; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Time Factors | 1984 |
A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Life Tables; Lymphoma; Neoplasms, Second Primary; Nervous System Diseases; Prospective Studies; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine | 1998 |
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Nausea; Prospective Studies; Regression Analysis; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vindesine; Vomiting | 1998 |
Chemosensitisation of malignant melanoma by BCL2 antisense therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; DNA, Antisense; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Proto-Oncogene Mas; Proto-Oncogene Proteins c-bcl-2; Skin; Skin Neoplasms; Survival Analysis; Treatment Outcome | 2000 |
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chills; Dacarbazine; Female; Fever; Follow-Up Studies; Hematologic Diseases; Humans; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Nausea; Remission Induction; Survival Analysis; Treatment Outcome; Vomiting | 2001 |
High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Dacarbazine; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Remission Induction; Sarcoma; Soft Tissue Neoplasms | 1991 |
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Remission Induction; Skin Neoplasms; Survival Rate | 1991 |
High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Cisplatin; Dacarbazine; Drug Evaluation; Female; Hematologic Diseases; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Remission Induction; Skin Neoplasms; Tamoxifen | 1991 |
High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Evaluation; Female; Hematologic Diseases; Humans; Kidney Diseases; Male; Melanoma; Middle Aged; Nervous System Diseases; Remission Induction; Survival Rate | 1991 |
18 other study(ies) available for dacarbazine and Blood Diseases
| Article | Year |
|---|---|
Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: a clinical audit.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cohort Studies; Community-Acquired Infections; Dacarbazine; Female; Glioma; Hematologic Diseases; Humans; Logistic Models; Male; Middle Aged; Neutropenia; Predictive Value of Tests; Temozolomide; Thrombocytopenia | 2013 |
An automated system for detecting nonadherence in laboratory testing and monitoring for myelosuppression in patients receiving self-administered oral chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Blood Cell Count; Brain Neoplasms; Clinical Laboratory Services; Dacarbazine; Female; Glioblastoma; Hematologic Diseases; Humans; Male; Medication Adherence; Middle Aged; Self Administration; Software; Temozolomide | 2013 |
Retrospective analysis of bevacizumab in combination with ifosfamide, carboplatin, and etoposide in patients with second recurrence of glioblastoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Interferons; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome | 2013 |
Toxicity and outcome of radiotherapy with concomitant and adjuvant temozolomide in elderly patients with glioblastoma: a retrospective study.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Cognition Disorders; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Promoter Regions, Genetic; Retrospective Studies; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins | 2014 |
Acute toxic effects of single dose dacarbazine: hematological and histological changes in an animal model.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Cricetinae; Dacarbazine; Dose-Response Relationship, Drug; Fibrosarcoma; Hematologic Diseases; Hepatitis; Humans; Male; Pneumonia; Treatment Outcome | 2014 |
Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Glioma; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Republic of Korea; Retrospective Studies; Severity of Illness Index; Sex Factors; Temozolomide; Vomiting; Young Adult | 2014 |
Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Comorbidity; Dacarbazine; Female; Glioblastoma; Hematologic Diseases; Humans; Longitudinal Studies; Male; Middle Aged; Prevalence; Radiotherapy, Conformal; Republic of Korea; Risk Factors; Survival Rate; Temozolomide; Treatment Outcome; Young Adult | 2015 |
[Risk factors for hematologic toxicity and multifaceted analysis of blood in Hodgkin's disease: a model for hematologic toxicity].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Discriminant Analysis; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Male; Middle Aged; Models, Statistical; Prognosis; Risk Factors; Vinblastine | 2010 |
[Benefit of a prolonged adjuvant treatment with temozolomide for the management of patients with glioblastoma].
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Glioblastoma; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Palliative Care; Radiotherapy, Conformal; Retrospective Studies; Temozolomide; Treatment Outcome | 2011 |
Hematologic adverse events associated with temozolomide.
Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents, Alkylating; Dacarbazine; Databases, Factual; Hematologic Diseases; Humans; Risk; Temozolomide; Time Factors; United States; United States Food and Drug Administration | 2012 |
Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematologic Diseases; HIV Infections; HIV Protease Inhibitors; Hodgkin Disease; Humans; Incidence; Kaplan-Meier Estimate; Lopinavir; Lung Diseases; Male; Mechlorethamine; Middle Aged; Nervous System Diseases; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Ritonavir; Vinblastine; Vincristine | 2012 |
A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Therapy; Chemotherapy, Adjuvant; Cisplatin; Dacarbazine; Female; Hematologic Diseases; Humans; Interferon-alpha; Interleukin-2; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Postoperative Complications; Prognosis; Retrospective Studies; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vinblastine; Young Adult | 2012 |
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Glyoxal; Hematologic Diseases; Hodgkin Disease; Humans; Ifosfamide; Male; Prednimustine; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Clinical Trials, Phase I as Topic; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Hematologic Diseases; Humans; Kidney; Lymphoma; Maximum Tolerated Dose; Meningeal Neoplasms; Neoplasm Recurrence, Local; Rituximab; Temozolomide; Treatment Outcome | 2005 |
Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.
Topics: Aged; Bronchial Neoplasms; Carcinoid Tumor; Dacarbazine; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Temozolomide; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Temozolomide in pediatric low-grade glioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Female; Hematologic Diseases; Humans; Male; Nausea; Radiography; Retrospective Studies; Spinal Cord Neoplasms; Survival Rate; Temozolomide; Vincristine | 2007 |
The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Dacarbazine; Female; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Pulmonary Embolism; Skin Neoplasms; Tamoxifen; Thrombophlebitis | 1989 |
Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dactinomycin; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Mitolactol | 1985 |